Hodgkin Lymphoma Treatment Shows Promise in Small Trial
Nivolumab harnesses power of immune system to attack cancer in patients who’ve failed other therapyContinue Reading
Nivolumab harnesses power of immune system to attack cancer in patients who’ve failed other therapyContinue Reading
Fewer than one in 10 forgot their daily dose after cellphone prompt, study saysContinue Reading
Those with damage due to lack of blood flow more likely to suffer recurrenceContinue Reading
Those with damage due to lack of blood flow more likely to suffer recurrenceContinue Reading
But further research is needed to explore impact, study authors sayContinue Reading
Physical activity reduced risk factors for diabetes, study saysContinue Reading
Vision-related complications can range from dry eye to night blindnessContinue Reading
Longer operations are associated with higher riskContinue Reading
Longer operations are associated with higher riskContinue Reading
Limiting radiation, costs should be objectives, researcher saysContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.